Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Placenta ; 29(1): 44-50, 2008 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-17959245

RESUMO

Term placental villous fragments from normotensive pregnant women were incubated under hypoxia in order to induce lipid peroxidation of the placental plasma membranes and, consequently, to increase their release of lipid peroxide products into the incubation medium. The homogenates of the villous fragments were assayed for plasma membrane Ca-ATPase (PMCA) activity and TBARS. The incubation medium, after placental hypoxia, was used to incubate intact red blood cells (RBCs) from normotensive pregnant women. Similarly, intact RBCs from normotensive pregnant women were incubated with deproteinized blood plasma from normotensive pregnant women and women with preeclampsia. In all the cases, red cell ghosts were prepared from the incubated cells and assayed for PMCA and TBARS. The incubation of placental villous fragments under hypoxia led to an increase in the TBARS and a significant reduction in the PMCA activity of their homogenates, as compared to those of villous fragments incubated under normoxia. The exposure of intact RBCs from normotensive pregnant women either to the incubation medium of placental hypoxia or to deproteinized blood plasma from women with preeclampsia, caused a rise of the TBARS and a diminution of PMCA activity of the red cell ghosts. Inside-out vesicles were also prepared from intact RBCs incubated with the medium where the placental hypoxia was carried out. These vesicles were assayed for active calcium transport. Pretreatment of RBCs with the incubation medium of placental hypoxia led to a lower active calcium transport as compared to that of inside-out vesicles from RBCs without any preincubation. These results are in agreement with the idea that the RBCs can be peroxidized when passing through a highly oxidized medium, such as the placental intervillous space from women with preeclampsia. The peroxidized RBCs would contribute then to the propagation of lipid peroxidation from the placenta to nearby and far away tissues.


Assuntos
Membrana Eritrocítica/enzimologia , Hipóxia/enzimologia , Peroxidação de Lipídeos , Placenta/enzimologia , ATPases Transportadoras de Cálcio da Membrana Plasmática/metabolismo , Trofoblastos/enzimologia , Feminino , Humanos , Placenta/citologia , ATPases Transportadoras de Cálcio da Membrana Plasmática/análise , Gravidez , Substâncias Reativas com Ácido Tiobarbitúrico/análise , Substâncias Reativas com Ácido Tiobarbitúrico/metabolismo
2.
Invest Clin ; 42(1): 51-78, 2001 Mar.
Artigo em Espanhol | MEDLINE | ID: mdl-11294032

RESUMO

An established fact in the polycystic ovarian syndrome (POS) is an abnormal ovarian steroidogenesis. Though this suggest an intrinsic ovarian defect, the syndrome could also be influenced by factors outside the ovaries. Although of unknown etiology, the POS is one of the most frequent endocrine disorders in the gynecologic practice. The disorder is characterized by ultrasound findings of enlarged polycystic ovaries, hyperandrogenism, menstrual disorders, obesity and including the appearance of infertility. There are a series of mechanisms involved in the extraovarian androgen increase in patients with POS. Among these mechanisms are implicated those of central and peripheral origin, genetic factors and adrenocortical dysfunction. In the same way, the alterations produced could imply genetic, molecular biological, biochemical, physiological and endocrinological factors. Sometimes all these factors could interact at the same time. The high serum androgen level could stop the pituitary gonadotropin production, either as a direct mechanism or as a result of its peripheral conversion. The increased androgens also explain the manifestations of clinical acne, hirsutism, and the detention in follicular ovarian maturation. All these manifestations are related with the menstrual disorders, anovulation, and infertility that these patients develop. The characteristics of the extraovarian POS include the 17-hydroxyprogesterone elevation in response to the ACTH test and the dexamethasone suppression of adrenal androgens. It is possible to improve the ovarian function in some patients with POS. This could be achieved with clomiphene citrate associated with glucocorticoids to induce ovulation.


Assuntos
Síndrome do Ovário Policístico/etiologia , Esteroides/metabolismo , 11-beta-Hidroxiesteroide Desidrogenases , 17-alfa-Hidroxiprogesterona/sangue , 3-Hidroxiesteroide Desidrogenases/deficiência , 3-Hidroxiesteroide Desidrogenases/genética , Córtex Suprarrenal/metabolismo , Hiperplasia Suprarrenal Congênita/complicações , Hiperfunção Adrenocortical/complicações , Hormônio Adrenocorticotrópico , Adulto , Androgênios/metabolismo , Catecolaminas/fisiologia , Clomifeno/uso terapêutico , Hormônio Liberador da Corticotropina/fisiologia , Cortisona/uso terapêutico , Dexametasona/uso terapêutico , Feminino , Glucocorticoides/metabolismo , Hormônios Esteroides Gonadais/metabolismo , Humanos , Hidroxiesteroide Desidrogenases/deficiência , Hidroxiesteroide Desidrogenases/genética , Hiperinsulinismo/complicações , Hiperprolactinemia/complicações , Sistema Hipotálamo-Hipofisário/fisiopatologia , Recém-Nascido , Infertilidade Feminina/tratamento farmacológico , Infertilidade Feminina/etiologia , Resistência à Insulina , Leptina/sangue , Mineralocorticoides/metabolismo , Obesidade/complicações , Ovário/metabolismo , Indução da Ovulação , Sistema Hipófise-Suprarrenal/fisiopatologia , Síndrome do Ovário Policístico/genética , Síndrome do Ovário Policístico/metabolismo , Pseudogravidez/etiologia , Esteroide 11-beta-Hidroxilase/genética , Esteroide 17-alfa-Hidroxilase/genética , Esterol Esterase/deficiência , Esterol Esterase/genética , Estresse Psicológico/complicações , Estresse Psicológico/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA